The prosecution announced on February 20 that local bioresearch centers falsified test results for six generic drugs each produced by six local companies.
The drugs include Hyundai Pharm's Levotuss, Hanmi Pharm's Fedipin 24/Ceftil, Pharmirae's Nifedipina, Whanin Pharm's Nifel S and Dream Pharma's Iterazole.
The Korea Food and Drug Administration (KFDA) said it will retract its approval fo...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.